Skip to main content

Esterified Estrogens Tablet Shortage

Last Updated: July 29, 2025
Status: Discontinued

To Be Discontinued:

Menest, Tablet, .3 mg (Pfizer Inc.)

NDC Code: 61570-072-01
Status: To Be Discontinued
Date of update: July 29, 2025
Update type: New
Related Information: Discontinuation of the manufacture of the drug
Therapeutic category: Endocrinology/Metabolism
Date discontinued: July 29, 2025
Initial posting date: July 29, 2025
Contact info: 800-533-4535

Menest, Tablet, .625 mg (Pfizer Inc.)

NDC Code: 61570-073-01
Status: To Be Discontinued
Date of update: July 29, 2025
Update type: New
Related Information: Discontinuation of the manufacture of the drug
Therapeutic category: Endocrinology/Metabolism
Date discontinued: July 29, 2025
Initial posting date: July 29, 2025
Contact info: 800-533-4535

Menest, Tablet, 1.25 mg (Pfizer Inc.)

NDC Code: 61570-074-01
Status: To Be Discontinued
Date of update: July 29, 2025
Update type: New
Related Information: Discontinuation of the manufacture of the drug
Therapeutic category: Endocrinology/Metabolism
Date discontinued: July 29, 2025
Initial posting date: July 29, 2025
Contact info: 800-533-4535

Menest, Tablet, 2.5 mg (Pfizer Inc.)

NDC Code: 61570-075-50
Status: To Be Discontinued
Date of update: July 29, 2025
Update type: New
Related Information: Discontinuation of the manufacture of the drug
Therapeutic category: Endocrinology/Metabolism
Date discontinued: July 29, 2025
Initial posting date: July 29, 2025
Contact info: 800-533-4535

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer